Adherence to treatment: what is done in Sweden? Practice, education and research
Objective: The objective of this review was to identify the practice, education and research of pharmacists in Sweden in regard to adherence to treatment.
Methods: Medline was searched up to the end of February 2008. In addition to the Medline search performed, other available sources were also used to identify relevant articles.
Results: No adherence-specific programs have been implemented in Swedish pharmacies. No adherence-specific courses are provided in Swedish Universities educating pharmacists. The adherence-related research has so far mainly focused on refill non-adherence, primary non-adherence and patient reported non-adherence and readiness to treatment.
Conclusions: Adherence-related practice and education of pharmacists will probably change due to the deregulation of the pharmacy market that will take place in the near future in Sweden. Research on adherence will need to be strengthened in the sense that it has so far not been guided by adherence-related theoretical frameworks, despite the fact that there are several theories to hand that try to explain adherence.
2. Compliance in health care. Baltimore: The Johns Hopkins University Press; 1979.
3. Kyngas H, Duffy ME, Kroll T. Conceptual analysis of compliance. J Clin Nurs. 2000;9(1):5-12.
4. Carpenter R. Perceived threat in compliance and adherence research. Nurs Inq. 2005;12(3):192-199.
5. Adherence to long-term therapies - Evidence for action. Geneva: World Health Organization; 2003.
6. Blenkinsopp A, Bond C, Britten N, Feely M, George C, Green P, et al. From compliance to concordance - achieving shared goals in medicine taking. London; 1997.
7. Fincham JE, Wertheimer AI. Using the health belief model to predict initial drug therapy defaulting. Soc Sci Med. 1985;20(1):101-105.
8. ABLA. Förbättrad läkemedelsanvändning genom bättre följsamhet till läkemedelsordinationen. Förslag till gemensamma mål för läkare, sjuksköterskor och farmaceuter. Stockholm; 1999.
9. ABLA. Mindre sjukdom och bättre hälsa genom ökad följsamhet till läkemedelsordinationerna - Professionernas roll. Stockholm; 2001.
10. ABLA. Bättre användning av läkemedel - Rapport från ABLA III projektet. Stockholm; 2005.
11. Krigsman K, Bastholm Rahmner P, Fuchs R, Nordstöm-Torpenberg I, Pettersson S, Nilsson JLG. Rational Use of Medicine - Use of concordance to improve patient adherence. WHO Drug Information. 2007;21(1):30-35.
12. Nilsson JLG, Andersson Å, Kälvemark S, Lieberman-Ram H, Ullenius B, Wendel A, Åberg Å.. surveys of drug-related therapy problems of patients using medicines for allergy, asthma and pain. Int J Pharm Pract. 2000;8:198-203.
13. Westerlund T, Handl WH, Marklund BR, Allebeck P. Pharmacy practitioners' views on computerized documentation of drug-related problems. Ann Pharmacother. 2003;37(3):354-360.
14. Westerlund T, Marklund BR, Handl WH, Thunberg ME, Allebeck P. Nonprescription drug-related problems and pharmacy interventions. Ann Pharmacother. 2001;35(11):1343-1349.
15. Westerlund T, Allebeck P, Marklund B, Andersson IL, Branstad JO, Sjoblom M. Evaluation of a model for counseling patients with dyspepsia in Swedish community pharmacies. Am J Health Syst Pharm. 2003;60(13):1336-1341.
16. Westerlund T, Almarsdottir AB, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci. 1999;21(6):245-250.
17. Westerlund T, Andersson IL, Marklund B. The quality of self-care counselling by pharmacy practitioners, supported by IT-based clinical guidelines. Pharm World Sci. 2007;29(2):67-72.
18. Westerlund T, Bjork HT. Pharmaceutical care in community pharmacies: practice and research in Sweden. Ann Pharmacother. 2006;40(6):1162-1169.
19. Montgomery AT, Kalvemark-Sporrong S, Henning M, Tully MP, Kettis-Lindblad A. Implementation of a pharmaceutical care service: prescriptionists', pharmacists' and doctors' views. Pharm World Sci. 2007;29(6):593-602.
20. Sodergard BM, Baretta K, Tully MP, Lindblad AK. A qualitative study of health-care personnel's experience of a satellite pharmacy at a HIV clinic. Pharm World Sci. 2005;27(2):108-115.
21. Bremberg ER, Hising C, Nylen U, Ehrsson H, Eksborg S. An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital. J Oncol Pharm Pract. 2006;12(2):75-81.
22. Bremberg ER, Rotstein S, Eksborg S. Treatment modifications of antineoplastic drugs in an oncology day-care unit. Acta oncologica (Stockholm). 2007;46(6):735-740.
23. Midlov P, Bondesson A, Eriksson T, Petersson J, Minthon L, Hoglund P. Descriptive study and pharmacotherapeutic intervention in patients with epilepsy or Parkinson's disease at nursing homes in southern Sweden. Eur J Clin Pharmacol. 2002;57(12):903-910.
24. Bondesson A, Midlov P, Eriksson T, Hoglund P. Pharmacotherapeutic interventions by a multi-specialty team: opinions of the general practitioners and nurses. Eur J Clin Pharmacol. 2003;59(1):65-69.
25. Högskoleverket. Utvärdering av apotekar- och receptarieutbildningarna vid svenska universitet och högskolor Stockholm; 2007.
26. Beckman Gyllenstrand A. Medication management and patient compliance in old age: Karolinska Institutet; 2007.
27. Krigsman K. Refill Adherence to Long-Term Drug Treatment with a Focus on Asthma/COPD Medication: Uppsala University; 2007.
28. Södergård B. Adherence and Readiness to Antiretroviral Treatment. Uppsla: Uppsala University; 2006.
29. Westerlund T. Drug-related problems, counseling, dyspepsia, IT-based documentation, OTC, pharmaceutical care, pharmacy interventions, pharmacy practice, referrals, self-medication, Sweden: University of Gothenburg; 2002.
30. Ekedahl A, Wessling A, Melander A. Primary non-compliance with automated prescription transmittals from health care centers in Sweden. J Soc Adm Pharm. 2002;19(4):137-140.
31. Ekedahl A, Mansson N. Unclaimed prescriptions after automated prescription transmittals to pharmacies. Pharm World Sci. 2004;26(1):26-31.
32. Ekedahl AB. Reasons why medicines are returned to Swedish pharmacies unused. Pharm World Sci. 2006;28(6):352-8.
33. Ekedahl A, Oskarsson V, Sundberg B, Gustafsson V, Lundberg T, Gullberg B. Impact of postal and telephone reminders on pick-up rates of unclaimed e-prescriptions. Pharm World Sci. 2008;30(5):503-508.
34. Andersson K, Melander A, Svensson C, Lind O, Nilsson JL. Repeat prescriptions: refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication. Eur J Public Health. 2005;15(6):621-626.
35. Krigsman K, Melander A, Carlsten A, Ekedahl A, Nilsson JL. Refill non-adherence to repeat prescriptions leads to treatment gaps or to high extra costs. Pharm World Sci. 2007;29(1):19-24.
36. Krigsman K, Moen J, Nilsson JL, Ring L. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. J Clin Pharm Ther. 2007;32(6):603-611.
37. Krigsman K, Nilsson JL, Ring L. Adherence to multiple drug therapies: refill adherence to concomitant use of diabetes and asthma/COPD medication. Pharmacoepidemiol Drug Saf. 2007;16(10):1120-1128.
38. Krigsman K, Nilsson JL, Ring L. Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacoepidemiol Drug Saf. 2007;16(4):441-448.
39. Nilsson JL, Andersson K, Bergkvist A, Bjorkman I, Brismar A, Moen J. Refill adherence to repeat prescriptions of cancer drugs to ambulatory patients. Eur J Cancer Care (Engl). 2006;15(3):235-237.
40. Haupt D, Krigsman K, Nilsson JL. Medication persistence among patients with asthma/COPD drugs. Pharm World Sci. 2008;30(5):509-514.
41. Södergård B, Halvarsson M, Lindback S, Sonnerborg A, Tully MP, Lindblad AK. Differences in adherence and motivation to HIV therapy--two independent assessments in 1998 and 2002. Pharm World Sci. 2006;28(4):248-256.
42. Södergård B, Halvarsson M, Tully MP, Mindouri S, Nordström ML, Lindbäck S, Sönnerborg A, Lindblad AK. Adherence to treatment in Swedish HIV-infected patients. J Clin Pharm Ther. 2006;31(6):605-616.
43. Westerlund M, Branstad JO, Westerlund T. Medicine-taking behaviour and drug-related problems in adolescents of a Swedish high school. Pharm World Sci. 2008;30(3):243-250.
44. Nordqvist O, Sodergard B, Tully MP, Sonnerborg A, Lindblad AK. Assessing and achieving readiness to initiate HIV medication. Patient Educ Couns. 2006;62(1):21-30.
45. Södergård B, Höfer S, Halvarsson M, Sonnerborg A, Tully MP, Lindblad AK. A structural equation modeling approach to the concepts of adherence and readiness in antiretroviral treatment. Patient Educ Couns. 2007;67(1-2):108-116.
46. Södergård BM, Halvarsson M, Brannstrom J, Sonnerborg A, Tully MP, Lindblad AK. Willey´s 2-item readiness assessment used in a Swedish sample of HIV-infected patients with antiretroviral treatment. 8th International Congress on Drug Therapy in HIV Infection 2006; Glasgow, UK; 2006.
47. Mardby AC, Akerlind I, Jorgensen T. Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns. 2007;69(1-3):158-164.
48. Ramstrom H, Afandi S, Elofsson K, Petersson S. Differences in beliefs between patients and pharmaceutical specialists regarding medications. Patient Educ Couns. 2006;62(2):244-249.
49. Beckman A, Bernsten C, Parker MG, Thorslund M, Fastbom J. The difficulty of opening medicine containers in old age: a population-based study. Pharm World Sci. 2005;27(5):393-398.
50. Beckman AG, Parker MG, Thorslund M. Can elderly people take their medicine? Patient Educ Couns. 2005;59(2):186-191.
51. Fallsberg M. Reflections on medicines and medication - a qualitative analysis among people on long-term drug regimens: Linköping University; 1991.
52. Kjellgren KI. Antihypertensive medication in clinical practice: Linköping University; 1998.
53. Eriksson LE. HIV therapies - from health related quality of life to DNA levels: Karolinska Institutet; 2003.
54. Cederfjäll C. Aspects of care among HIV infected patients : Needs, adherence to treatment and health related quality of life Karolinska Institutet; 2002.
55. Hagström B. Medication and compliance. Studies from a general practice perspective: Göteborgs University; 2007.
56. Johnell K. Contextual and individual aspects of use of medication. Multilevel studies on anxiolytic-hypnotic drug use, social context, adherence to medication, and disability pension: Karolinska Institutet; 2005.
57. Alm-Roijer C. Factors influencing adherence to risk factor modification in patients with coronary heart disease: Lund University; 2006.
58. Ulfvarson J. Drug treatment of elderly - the need for changing behaviour among providers and patients: Karolinska Institutet; 2004.
59. Wallman A, Lindblad AK, Hall S, Lundmark A, Ring L. A categorization scheme for assessing pharmacy students' levels of reflection during internships. Am J Pharm Educ. 2008;72(1):05.
The authors hereby transfer, assign, or otherwise convey to Pharmacy Practice: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print pr epublish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to Pharmacy Practice with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.